|Articles|February 2, 2005
- Pharmaceutical Technology-02-02-2005
- Volume 29
- Issue 2
Drug Safety Fears May Limit Reimporting and Shape R&D
Author(s)Jill Wechsler
Concerns about risky medicines may reduce pressure to expand drug imports while boosting demand for more comparative analyses of therapies.
Advertisement
Articles in this issue
about 21 years ago
Correcting the Courseabout 21 years ago
February 2005about 21 years ago
Good Work and True: USP Prepares for Convention 2005about 21 years ago
Contract Manufacturers Getting Squeezedabout 21 years ago
In the Spotlight-February 2005about 21 years ago
Emerging Analytical Technology: Moving from the Lab to the Lineabout 21 years ago
In Defense of USP Singlet TestingNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Shaping the Future of Microbial Development: From Gene to GMP
2
Bristol Myers Squibb and Johnson & Johnson Launch Educational Program for Thromboembolic R&D
3
WEF Welcomes ACG Shirwal as First Pharma Packaging Site in Global Lighthouse Network
4
FDA Launches PreCheck Pilot Program to Bolster Domestic Drug Manufacturing
5